• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 90 of 100
HealthThe drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
By Laura LorenzettiSeptember 29, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
HealthBiotech stocks dive as lawmakers take aim at Valeant for drug price hikes
By Laura LorenzettiSeptember 28, 2015
GOP Candidate For President Donald Trump Campaigns In Columbia, South Carolina
LeadershipDonald Trump on drug price-raising CEO: ‘Spoiled brat’
By Laura LorenzettiSeptember 24, 2015
Inside Teva Pharmaceuticals Headquarters
HealthHere are the 5 drug classes with the biggest price gains
By Laura LorenzettiSeptember 23, 2015
MSMB Capital Management CIO Martin Shkreli
HealthTuring backs down on Daraprim drug pricing
By TIMESeptember 23, 2015
157934085
HealthDoctors respond to Turing drug price hike: ‘It’s scare mongering’
By Laura LorenzettiSeptember 22, 2015
HIllary Rodham Clinton
HealthHillary Clinton releases health plan that aims to combat skyrocketing drug costs
By Laura LorenzettiSeptember 22, 2015
MSMB Capital Management CIO Martin Shkreli
HealthHere’s why Turing Pharmaceuticals says 5,000% price bump is necessary
By Laura LorenzettiSeptember 21, 2015
Picture taken on January 15, 2012 in Lil
HealthThis 62-year-old drug just got 5,000% more expensive
By Laura LorenzettiSeptember 21, 2015
Tom Insel, director of the National Institute of Mental Health, in Rockford.
TechGoogle’s NIH health hire: Smartphones can detect mental health breakdowns
By Kayt SukelSeptember 17, 2015
HealthHow the U.S. could cure drug-price insanity
By Peter B. Bach, MDSeptember 17, 2015
TechWalgreens taps Postmates to deliver to its customers at the tap of a button
By Kia KokalitchevaSeptember 15, 2015
LeadershipBlurred governance: Mylan’s illusions vs. BofA’s realities
By Jeffrey SonnenfeldSeptember 15, 2015
MPWThe change agent inside CVS
By Phil WahbaSeptember 11, 2015
Heather Bresch CEO of Mylan a global pharmaceutical company
MPWWhy Wall Street loves to hate Mylan’s CEO
By Jen WiecznerSeptember 11, 2015
1...
  • 88
  • 89
  • 90
  • 91
  • 92
...100
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.